Odonate Therapeutics Stock Fundamentals
| ODTCDelisted Stock | USD 1.80 0.00 0.00% |
Odonate Therapeutics fundamentals help investors to digest information that contributes to Odonate Therapeutics' financial success or failures. It also enables traders to predict the movement of Odonate Pink Sheet. The fundamental analysis module provides a way to measure Odonate Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Odonate Therapeutics pink sheet.
Odonate |
Odonate Therapeutics Company Return On Equity Analysis
Odonate Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Odonate Therapeutics Return On Equity | -0.86 |
Most of Odonate Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Odonate Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Odonate Therapeutics has a Return On Equity of -0.8614. This is 159.41% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on equity for all United States stocks is 177.87% higher than that of the company.
Odonate Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Odonate Therapeutics's current stock value. Our valuation model uses many indicators to compare Odonate Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Odonate Therapeutics competition to find correlations between indicators driving Odonate Therapeutics's intrinsic value. More Info.Odonate Therapeutics is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Odonate Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Odonate Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Odonate Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (26.67 M) | ||||
| Shares Outstanding | 38.49 M | ||||
| Shares Owned By Insiders | 3.61 % | ||||
| Shares Owned By Institutions | 9.60 % | ||||
| Number Of Shares Shorted | 379.63 K | ||||
| Price To Book | 0.89 X | ||||
| EBITDA | (125.91 M) | ||||
| Net Income | (126.35 M) | ||||
| Cash And Equivalents | 95.03 M | ||||
| Cash Per Share | 2.47 X | ||||
| Total Debt | 4.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 3.29 X | ||||
| Book Value Per Share | 1.85 X | ||||
| Cash Flow From Operations | (113.13 M) | ||||
| Short Ratio | 0.59 X | ||||
| Earnings Per Share | (2.71) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 137 | ||||
| Beta | 0.0342 | ||||
| Market Capitalization | 69.28 M | ||||
| Total Asset | 167.89 M | ||||
| Z Score | 8.4 | ||||
| Net Asset | 167.89 M |
About Odonate Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Odonate Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Odonate Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Odonate Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. The company was founded in 2013 and is based in New York, New York. Odonate Therapeutics operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 137 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Odonate Pink Sheet
If you are still planning to invest in Odonate Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Odonate Therapeutics' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |